APLP1
Basic information
Region (hg38): 19:35867899-35879803
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the APLP1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 33 | 34 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 33 | 1 | 1 |
Variants in APLP1
This is a list of pathogenic ClinVar variants found in the APLP1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-35868677-G-A | not specified | Uncertain significance (Jul 05, 2023) | ||
19-35869689-C-T | not specified | Uncertain significance (Mar 25, 2024) | ||
19-35869709-A-G | not specified | Uncertain significance (Nov 22, 2023) | ||
19-35869721-G-A | not specified | Uncertain significance (May 03, 2023) | ||
19-35869764-G-A | not specified | Uncertain significance (Mar 22, 2023) | ||
19-35870936-C-G | not specified | Uncertain significance (Oct 26, 2021) | ||
19-35870978-G-A | not specified | Uncertain significance (Jul 09, 2021) | ||
19-35870995-C-A | not specified | Uncertain significance (Mar 11, 2022) | ||
19-35871020-G-A | not specified | Likely benign (Jan 03, 2024) | ||
19-35871293-C-G | not specified | Uncertain significance (Mar 18, 2024) | ||
19-35871697-T-C | not specified | Uncertain significance (Dec 07, 2023) | ||
19-35871871-C-T | not specified | Uncertain significance (Oct 02, 2023) | ||
19-35871872-G-A | not specified | Uncertain significance (Aug 31, 2022) | ||
19-35871880-C-T | not specified | Uncertain significance (Feb 05, 2024) | ||
19-35871884-C-G | not specified | Uncertain significance (Dec 14, 2022) | ||
19-35871895-G-A | not specified | Uncertain significance (Jul 06, 2021) | ||
19-35871943-G-T | not specified | Uncertain significance (Feb 26, 2024) | ||
19-35871973-G-A | not specified | Uncertain significance (May 11, 2022) | ||
19-35871994-G-A | not specified | Uncertain significance (Jan 26, 2022) | ||
19-35872540-A-G | not specified | Uncertain significance (Aug 19, 2021) | ||
19-35872580-C-T | Benign (Apr 20, 2018) | |||
19-35873645-C-A | not specified | Uncertain significance (Nov 14, 2023) | ||
19-35873673-C-A | not specified | Uncertain significance (Jul 06, 2021) | ||
19-35873693-G-A | not specified | Uncertain significance (Mar 21, 2023) | ||
19-35874544-C-G | not specified | Uncertain significance (Oct 05, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
APLP1 | protein_coding | protein_coding | ENST00000221891 | 17 | 11893 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.122 | 0.878 | 125724 | 0 | 23 | 125747 | 0.0000915 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.21 | 324 | 392 | 0.828 | 0.0000246 | 4157 |
Missense in Polyphen | 137 | 179.06 | 0.76512 | 1941 | ||
Synonymous | -1.17 | 177 | 158 | 1.12 | 0.0000101 | 1348 |
Loss of Function | 4.17 | 9 | 36.0 | 0.250 | 0.00000188 | 374 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000262 | 0.000262 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000799 | 0.0000791 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000655 | 0.0000653 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: May play a role in postsynaptic function. The C-terminal gamma-secretase processed fragment, ALID1, activates transcription activation through APBB1 (Fe65) binding (By similarity). Couples to JIP signal transduction through C-terminal binding. May interact with cellular G-protein signaling pathways. Can regulate neurite outgrowth through binding to components of the extracellular matrix such as heparin and collagen I. {ECO:0000250}.;
Recessive Scores
- pRec
- 0.617
Intolerance Scores
- loftool
- 0.0546
- rvis_EVS
- -0.68
- rvis_percentile_EVS
- 15.36
Haploinsufficiency Scores
- pHI
- 0.334
- hipred
- Y
- hipred_score
- 0.597
- ghis
- 0.540
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.760
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Aplp1
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); growth/size/body region phenotype;
Gene ontology
- Biological process
- endocytosis;apoptotic process;cell adhesion;nervous system development;animal organ morphogenesis;cellular response to norepinephrine stimulus;negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway
- Cellular component
- basement membrane;plasma membrane;integral component of membrane;perinuclear region of cytoplasm
- Molecular function
- protein binding;heparin binding;alpha-2A adrenergic receptor binding;alpha-2B adrenergic receptor binding;alpha-2C adrenergic receptor binding;identical protein binding;transition metal ion binding